Loading...

enGene Holdings Inc. Warrants

ENGNW•NASDAQ
Healthcare
Biotechnology
$0.12
$-0.11(-47.83%)
U.S. Market opens in 49h 18m

enGene Holdings Inc. Warrants (ENGNW) Stock Overview

Explore enGene Holdings Inc. Warrants’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.8M
P/E Ratio-0.84
EPS (TTM)N/A
ROE-0.56%
Fundamental Analysis

AI Price Forecasts

1 Month$2.68
3 Months$2.49
1 Year Target$1.64

ENGNW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of enGene Holdings Inc. Warrants (ENGNW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 25.42, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $1.64.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.84 and a market capitalization of 5.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-50.78%
5-Day Change
-94.10%
1-Month Change
-94.92%
3-Month Change
-96.44%
6-Month Change
-92.45%
Year-to-Date (YTD) Change
-95.65%
1-Year Change
-84.70%
3-Year Change
-88.68%
5-Year Change
-88.68%
All-Time (Max) Change
-88.68%

Contact Information

https://www.engene.com
514 332 4888
4868 Rue Levy, Montreal, QC, H4S 1Z9

Company Facts

560 Employees
IPO DateFeb 1, 2022
CountryCA
Actively Trading

Frequently Asked Questions